Akebia Therapeutics, Inc. (AKBA)

NASDAQ: AKBA · Real-Time Price · USD

2.960

-0.060 (-1.99%)

At close: Sep 5, 2025, 4:00 PM

2.980

+0.020 (0.68%)

After-hours: Sep 5, 2025, 7:53 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2019
Novel Therapeutics	160.18M	Log In	Log In	Log In	Log In	Upgrade
Novel Therapeutics Growth	-17.70%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2019
United States	160.18M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-17.70%	Log In	Log In	Log In	Log In	Upgrade